CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)

Clinical trial NCT07576699 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07576699
Sponsor: Cellenkos, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Steroid Refractory Graft Versus Host Disease

Start date: 2026-07-01
Primary completion: 2028-06-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.